Novus Biologicals products are now on bio-techne.com

CCL2/JE/MCP-1 Antibody [Unconjugated]

Images

 
Western blot shows 25 ng of Recombinant Human CCL2/JE/MCP-1 (Catalog # 279-MC), Recombinant Mouse CCL2/JE/MCP-1 (Catalog # 479-JE), Recombinant Rat CCL2/JE/MCP-1 (Catalog # 3144-JE), Recombinant Human CCL7/MCP-3/MARC ...read more
CCL2/JE/MCP‑1 was detected in immersion fixed paraffin-embedded sections of human Crohn's disease intestine using Goat Anti-Human CCL2/JE/MCP‑1 Antigen Affinity-purified Polyclonal Antibody (Catalog # ...read more
Recombinant Human CCL2/MCP‑1 (Catalog # 279‑MC) chemoattracts the BaF3 mouse pro‑B cell line transfected with human CCR2A in a dose-dependent manner (orange line). The amount of cells that migrated through to the ...read more

Product Details

Summary
Reactivity HuSpecies Glossary
Applications WB, IHC, B/N
Clonality
Polyclonal
Host
Goat
Conjugate
Unconjugated
Concentration
LYOPH

Order Details

View Available Conjugates
Catalog# & Conjugate Size Price
View Available Formulations
Catalog# & Formulation Size Price
Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

CCL2/JE/MCP-1 Antibody [Unconjugated] Summary

Immunogen
E. coli-derived recombinant human CCL2/JE/MCP-1
Gln24-Thr99
Accession # P13500
Specificity
Detects human CCL2/JE/MCP-1 in direct ELISAs and Western blots.
Source
N/A
Isotype
IgG
Clonality
Polyclonal
Host
Goat
Gene
CCL2
Purity Statement
Antigen Affinity-purified
Endotoxin Note
<0.10 EU per 1 μg of the antibody by the LAL method.
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Applications/Dilutions

Dilutions
  • Immunohistochemistry 10-25 ug/mL
  • Neutralization 1.5-4.5 ug/mL
  • Western Blot 0.1 ug/mL
Publications
Read Publications using
AF-279-NA in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Preservative
No Preservative
Concentration
LYOPH
Reconstitution Instructions
Reconstitute at 0.2 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for CCL2/JE/MCP-1 Antibody [Unconjugated]

  • C-C motif chemokine ligand 2
  • CCL2
  • GDCF-2
  • HC11
  • HSMCR30
  • MCAF
  • Mcp1
  • MCP-1
  • SCYA2
  • SMC-CF

Background

CCL2, also known as monocyte chemotactic and activating factor (MCAF), was initially purified independently by two groups based on its ability to chemoattract monocytes. The human CCL2 cDNA encodes a 99 amino acid residue precursor protein with a 23 residue hydrophobic signal peptide that is cleaved to generate the 76 residue mature protein. Natural CCL2 is heterogeneous in size due to the addition of O-linked carbohydrates and sialic acid residues. In addition to fibroblasts; tumor cells, smooth muscle cells, endothelial cells, and mononuclear phagocytes can also produce CCL2 either constitutively or upon stimulation by various stimuli. CCL2 is a member of the  beta (C-C) subfamily of chemokines. The existence of MCP-2 and MCP-3 with 62% and 73% amino acid identity respectively, to CCL2 have been reported. Consistent with it being a member of the chemokine beta family, CCL2 has been shown to chemoattract monocytes. In addition, it will also activate monocytes to be cytostatic for some human tumor cell lines; to increase cytosolic free calcium; to generate and release monocyte superoxide anions and to release monocyte lysosomal enzymes in vitro. CCL2 was reported to be capable of regulating adhesion molecule expression and cytokine production in human monocytes as well as chemoattracting, activating, and inducing histamine release from basophils. The biological roles played by CCL2 in a number of inflammatory and non-inflammatory disease states characterized by the accumulation of leukocytes at the site of the lesion, including atherosclerosis, delayed hypersensitivity reactions, etc., are being determined. CCL2 can bind to the C-C chemokine receptor-1 that also binds MIP-1 alpha , RANTES and MIP-1 beta . A specific receptor for CCL2 has also been cloned from THP-1 and MonoMac 6 cells.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

MAB208
Species: Hu
Applications: CyTOF-ready, ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, ICFlow, Neut, Simple Western, WB
DRN00B
Species: Hu
Applications: ELISA
DY417
Species: Mu
Applications: ELISA
MAB150
Species: Hu
Applications: CyTOF-ready, Flow, IHC
NB100-56583
Species: Hu, Rb, Rt
Applications: Flow, IHC, IHC-P, KO, WB
DIP100
Species: Hu
Applications: ELISA
DVE00
Species: Hu
Applications: ELISA
AF796
Species: Mu
Applications: AdBlk, IHC, WB
MAB2005
Species: Hu
Applications: CyTOF-ready, Flow, WB
6507-IL/CF
Species: Hu
Applications: BA
NBP1-90214
Species: Hu
Applications: ICC/IF, IHC, IHC-P, WB
DY1707
Species: Hu
Applications: ELISA
AF1230
Species: Hu, Mu, Rt
Applications: IHC, KO, WB
201-LB
Species: Hu
Applications: BA
MAB1417
Species: Bv, Hu, Mu
Applications: CyTOF-ready, ICC, IHC, ICFlow
AF-279-NA
Species: Hu
Applications: WB, IHC, B/N

Publications for CCL2/JE/MCP-1 Antibody (AF-279-NA)(20)

We have publications tested in 4 confirmed species: Human, Rat, Primate - Macaca mulatta (Rhesus Macaque), Rabbit.

We have publications tested in 5 applications: ICC, IHC-Fr, IHC-P, Neutralization, Western Blot.


Filter By Application
ICC
(1)
IHC-Fr
(2)
IHC-P
(4)
Neutralization
(4)
Western Blot
(1)
All Applications
Filter By Species
Human
(8)
Rat
(1)
Primate - Macaca mulatta (Rhesus Macaque)
(2)
Rabbit
(1)
All Species
Showing Publications 1 - 10 of 20. Show All 20 Publications.
Publications using AF-279-NA Applications Species
Tsung-Lun Lee, Tien-Hua Chen, Ying-Ju Kuo, Hsin-Yi Lan, Muh-Hwa Yang, Pen-Yuan Chu Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma Neoplasia 2023-01-01 [PMID: 36410227]
L Wang, J Lan, J Tang, N Luo MCP-1 targeting: Shutting off an engine for tumor development Oncology Letters, 2021-11-19;23(1):26. 11/19/2021 [PMID: 34868363]
W Peng, D Rao, M Zhang, Y Shi, J Wu, G Nie, Q Xia Teneligliptin prevents doxorubicin-induced inflammation and apoptosis in H9c2 cells Arch. Biochem. Biophys., 2019-12-24;0(0):108238. 2019-12-24 [PMID: 31881187] (Western Blot, Rat) Western Blot Rat
Collin de l'Hortet A, Takeishi K, Guzman-Lepe J et al. Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism Cell Metab. 8/6/2019 [PMID: 31390551]
P. Lorenzo Bozzelli, Tao Yin, Valeria Avdoshina, Italo Mocchetti, Katherine E. Conant, Kathleen A. Maguire‐Zeiss HIV‐1 Tat promotes astrocytic release of CCL2 through MMP/PAR‐1 signaling Glia 2019-05-23 [PMID: 31124192]
Y Chen, M Zhong, G Yuan, H Peng Interleukin-17 induces angiogenesis in�vitro via CXCL8 and CCL2 in retinal pigment epithelium Mol Med Rep, 2018-01-18;0(0):. 1/18/2018 [PMID: 29363728]
P Molek, T Bratkovi? Epitope Mapping of Mono- and Polyclonal Antibodies by Screening Phage-displayed Random Peptide Libraries Acta Chim Slov, 2016-12-01;63(4):914-919. 12/1/2016 [PMID: 28004095]
Maria Hårdstedt, Susanne Lindblom, Alex Karlsson-Parra, Bo Nilsson, Olle Korsgren Characterization of Innate Immunity in an Extended Whole Blood Model of Human Islet Allotransplantation Cell Transplantation 2016-03-01 [PMID: 26084381]
Buonora JE, Yarnell AM, Lazarus RC et al. Multivariate analysis of traumatic brain injury: development of an assessment score. Front Neurol 3/30/2015 [PMID: 25870583]
Zhan Z, Xie X, Cao H, Zhou X, Zhang X, Fan H, Liu Z Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy, 2013-12-04;10(2):257-68. 2013-12-04 [PMID: 24321786] (Neutralization, Human) Neutralization Human
Show All 20 Publications.

Reviews for CCL2/JE/MCP-1 Antibody (AF-279-NA) (0)

There are no reviews for CCL2/JE/MCP-1 Antibody (AF-279-NA). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

Video Protocols

WB Video Protocol

FAQs for CCL2/JE/MCP-1 Antibody (AF-279-NA) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.
mFluor Violet Conjugated Antibodies

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our CCL2/JE/MCP-1 Antibody [Unconjugated] and receive a gift card or discount.

Bioinformatics

Gene Symbol CCL2
Uniprot